36 devices · GMDN 58846
Alternating electric field antimitotic cancer treatment system transducer arrays are single-use, sterile devices designed to deliver low-intensity alternating electric fields to the brain. Clinically, they are used as part of a treatment system for certain cancers, such as glioblastoma multiforme (GBM), by disrupting cancer cell division while sparing healthy tissue.
These devices are typically regulated as single-use medical devices and are supplied as part of a larger treatment system. They are worn continuously for 3–4 days before disposal and require connection to an external alternating current generator for operation.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.